XSHG
600064
Market cap2.07bUSD
Oct 09, Last price
7.99CNY
1D
-0.37%
1Q
9.15%
Jan 2017
6.82%
Name
Nanjing Gaoke Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Nanjing, China, in 1992, Nanjing Gaoke Company Limited operates as a diversified enterprise with its core business centered on real estate development, particularly commercial and residential properties across China. The company's extensive operations also encompass significant infrastructure projects, including community revitalization, the construction of new roads, and the development of mountain parks. It provides a comprehensive range of construction and engineering services, such as residential building, municipal engineering (including supervision), landscaping, wastewater treatment, and water utility provisions. Additionally, the firm offers property management, land utilization planning, architectural and engineering design, and environmental protection project implementation. Beyond these activities, Nanjing Gaoke is actively engaged in a broad spectrum of investment ventures, including industrial investment, venture capital, securities trading, and offering investment management and consulting. A key part of its financial services includes providing financing support to small and medium-sized technology firms and emerging startups. Further diversifying its portfolio, the company manufactures and distributes both traditional Chinese and Western pharmaceutical preparations, offers medical and healthcare advisory services, and provides property leasing options.
Key people
Kejin Zhou
Chief Financial Officer · since 2016
Zhao Guo
Vice President · since 2013
Chen Lu
Vice President · since 2009
Yangjun Lu
Vice President · since 2016
Jianhui Xie
Secretary of the Board · since 2010
Chairman of the Board · since 2013
Independent Director
Independent Director · since 2009
Headquarters & legal address
南京经济技术开发区恒通大道2号
南京市, JS 100000
CN
南京市, JS 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||